Printer Friendly

AstraZeneca contributes USD25000 at groundbreaking of new La Red Health facility in Sussex county.

M2 EQUITYBITES-February 7, 2011-AstraZeneca contributes USD25000 at groundbreaking of new La Red Health facility in Sussex county(C)2011 M2 COMMUNICATIONS

Biopharmaceutical company AstraZeneca (NYSE:AZN) on Friday announced a USD250,000 contribution that will help the La Red Health Centre build a new 15,000-square-foot facility.

The new facility will provide care to more patients in Sussex county. The new La Red facility is expected to have significantly more space for waiting and examination rooms and will offer dental care, a new clinical service, the company said.

AstraZeneca is part of a public-private collaborative effort to support this expansion of health care services in Sussex county. AstraZeneca's partnership with La Red Health Center began in 2007 with the launch of 'Healthy Delawareans Today & Tomorrow', a public-private coalition aimed at increasing the awareness and availability of free and low-cost healthcare services for uninsured and underinsured Delawareans.

AstraZeneca said that it continues to support La Red's patient navigation efforts to help connect people with the services and programs they need.

La Red Health Center's, (LRHC) mission is to provide bilingual, culturally appropriate, high-quality, cost-effective, primary and preventive medical care to residents of Sussex County, Delaware. The emphasis is on those who are underinsured, uninsured or who face other barriers to medical care.

((Comments on this story may be sent to>PDFebruary 7, 2011>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Feb 7, 2011
Previous Article:AOL to acquire The Huffington Post for USD315m.
Next Article:Bohai Pharmaceuticals names Anthony Chan and Gene Hsiao as independent directors.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters